Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels
Milan J. Sonneveld(Erasmus MC), Benjamin Maasoumy(Medizinische Hochschule Hannover), Markus Cornberg(Medizinische Hochschule Hannover), Sang Hoon Ahn(Yonsei University), George Ν. Dalekos(University Hospital of Larissa), Yasuhito Tanaka(Kumamoto University), Nicole S. Erler(Erasmus MC), Ivana Carey(King's College London), Sylvia M. Brakenhoff(Erasmus MC), George Papatheodoridis(National and Kapodistrian University of Athens), Teerha Piratvisuth(Prince of Songkla University), Marı́a Buti(Vall d'Hebron Hospital Universitari), Fabien Zoulim(Hôpital de la Croix-Rousse), Man‐Fung Yuen(University of Hong Kong - Shenzhen Hospital), Kosh Agarwal(King's College - North Carolina), Florian van Bömmel(University Hospital Leipzig), Apichat Kaewdech(Prince of Songkla University), Heiner Wedemeyer(Medizinische Hochschule Hannover), Μargarita Papatheodoridi(Laiko General Hospital of Athens), Thomas Berg(Leipzig University of Applied Sciences), Jun Yong Park(Yonsei University), Chien‐Hung Chen(Kaohsiung Chang Gung Memorial Hospital), Shao‐Ming Chiu(Kaohsiung Chang Gung Memorial Hospital), André Boonstra(Erasmus MC), Wai‐Kay Seto(State Key Laboratory of Synthetic Chemistry), Christoph Höner zu Siederdissen(Medizinische Hochschule Hannover)
Cited by 121
Related Papers
ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
|New England Journal of Medicine|2014|877
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
|Journal of Hepatology|2016|817
Hepatitis B Virus Resistance to Nucleos(t)ide Analogues
|Gastroenterology|2009|693
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis
|New England Journal of Medicine|2018|605
Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region
|Gut and Liver|2016|512